NCT01040156已完成不适用
Safety, Feasibility and Efficacy of Caspofungin Versus Liposomal Amphotericin B as Antifungal Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients - a Retrospective Phase I/II Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
Pediatric patients are at high risk to acquire mycotic infections following allogeneic bone marrow transplantation. In the present retrospective analysis we assess the safety and efficacy of different regimens in antimycotic prophylaxis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- — 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pediatric patients under the age of 18 years
- •Pediatric patients after HSCT treated with caspofungin
- •Pediatric patients after HSCT treated with liposomal amphotericin
排除标准
- •Pediatric patients with uncontrolled hematological malignancies
- •Pediatric patients with IFI at start of HSCT
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)Invasive Fungal InfectionNCT01888458Nantes University Hospital21
已完成
1 期
Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell TransplantationOral MucositisHematopoietic Stem Cell TransplantationNCT00701688St. Jude Children's Research Hospital19
已完成
1 期
Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHDGraft Versus Host DiseaseNCT02824653National Institute of Blood and Marrow Transplant (NIBMT), Pakistan10
已完成
不适用
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and NeutropeniaFebrile NeutropeniaNCT00723073Brigham and Women's Hospital323
Unknown
2 期
Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS)ARDSCOVID-19NCT04377334University Hospital Tuebingen40